Cargando…

Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency

Detalles Bibliográficos
Autores principales:	Hirsiger, Julia R., Weigang, Sebastian, Walz, Antje-Christine, Fuchs, Jonas, Daly, Mary-Louise, Eggimann, Stefan, Hausmann, Oliver, Schwemmle, Martin, Kochs, Georg, Panning, Marcus, Warnatz, Klaus, Recher, Mike, Berger, Christoph T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2022
Materias:	Clinical Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239915/ https://www.ncbi.nlm.nih.gov/pubmed/35779780 http://dx.doi.org/10.1016/j.jaip.2022.06.020

Ejemplares similares

Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests
por: Hunsperger, Elizabeth A., et al.
Publicado: (2009)

Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays
por: Johnson, Barbara W., et al.
Publicado: (2016)

Evaluation of three commercially-available chikungunya virus immunoglobulin G immunoassays
por: De Salazar, Pablo M, et al.
Publicado: (2017)

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
por: Jaki, Lena, et al.
Publicado: (2023)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV
por: Baroncelli, Silvia, et al.
Publicado: (2022)

Commercially available accelerators
por: Barbalat, Oscar
Publicado: (1996)

REAGINIC ACTIVITY ASSOCIATED WITH IGG IMMUNOGLOBULIN
por: Reid, Robert T., et al.
Publicado: (1966)

Analysis of Specific IgG Titers Against Tick-Borne Encephalitis in Patients with Primary Antibody Deficiency Under Immunoglobulin Substitution Therapy: Impact of Plasma Donor Origin
por: Goldacker, Sigune, et al.
Publicado: (2015)

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
por: Weigang, Sebastian, et al.
Publicado: (2021)

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020)

Limited specificity of commercially available SARS‐CoV‐2 IgG ELISAs in serum samples of African origin
por: Emmerich, Petra, et al.
Publicado: (2021)

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Upasani, Vinit, et al.
Publicado: (2023)

Immunodeficiency in adults a practical guide for the allergist
por: Hausmann, Oliver, et al.
Publicado: (2014)

A NEW MOUSE IMMUNOGLOBULIN: IGG3
por: Grey, Howard M., et al.
Publicado: (1971)

Passive blood anaphylaxis: subcutaneous immunoglobulins are a cause of ongoing passive anaphylactic reaction
por: Zdziarski, Przemyslaw, et al.
Publicado: (2017)

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2021)

Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies
por: Kaduskar, Ojas, et al.
Publicado: (2021)

Correction to: Passive blood anaphylaxis: subcutaneous immunoglobulins are a cause of ongoing passive anaphylactic reaction
por: Zdziarski, Przemyslaw, et al.
Publicado: (2018)

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2
por: Taddeo, Adriano, et al.
Publicado: (2022)

Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation
por: Hirsiger, Julia R, et al.
Publicado: (2019)

Commercially available alternatives to palm oil
por: Hinrichsen, Nils
Publicado: (2016)

Validity of Commercially Available Punch Trackers
por: Omcirk, Dan, et al.
Publicado: (2023)

Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays
por: Poore, Brad, et al.
Publicado: (2021)

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant
por: Lindahl, Hannes, et al.
Publicado: (2022)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion
por: Hirsiger, Julia R., et al.
Publicado: (2023)

Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking
por: Bergström, Joakim J. E., et al.
Publicado: (2017)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

How valid are commercially available medical simulators?
por: Stunt, JJ, et al.
Publicado: (2014)

Thermodynamic effects of commercially available ice boots
por: Quintanar, Madison N., et al.
Publicado: (2018)

Passive Auditory Stimulation Improves Vision in Hemianopia
por: Lewald, Jörg, et al.
Publicado: (2012)

Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
por: Walker, Gregory J., et al.
Publicado: (2021)

Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies
por: Ehrenstein, Michael R., et al.
Publicado: (2000)

Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model
por: Zhao, Yongkun, et al.
Publicado: (2017)

Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy
por: Flicker, Sabine, et al.
Publicado: (2013)

Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against Receptor binding domain and full length spike protein of SARS-CoV-2
por: Kwatra, Gaurav, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n25tajbg19bedqg4an2su16nq6